芬吗通片对月经失调患者的总有效率分析  

Analysis of total effective rate of fenmotong tablets in patients with menstrual disorders

在线阅读下载全文

作  者:赵霞 ZHAO Xia(Department of Obstetrics and Gynecology,big bridge hospital of Zhengzhou,zhengzhou,453003,China)

机构地区:[1]郑州大桥医院妇产科,郑州453003

出  处:《新疆医学》2022年第9期1068-1070,共3页Xinjiang Medical Journal

摘  要:目的分析芬吗通片对月经失调患者的总有效率。方法入组研究对象是2018年5月-2020年5月本院116例月经失调患者,分组依照随机法(每组n=58),参照组采纳克龄蒙片治疗,病例组采纳芬吗通片治疗,对比两组临床疗效、卵巢激素水平、不良反应发生率、SF-36评分。结果病例组临床总有效率(96.55%)高于参照组(74.14%),病例组治疗后血清E以及P均高于参照组,差异均具有统计学意义(P<0.05)。病例组不良反应发生率(3.45%)低于参照组(15.52%),病例组治疗后SF-36评分高于参照组,差异均具有统计学意义(P<0.05)。结论芬吗通片可有效调节月经失调患者月经周期、卵巢激素水平,提高生活质量,且不良反应较少,值得借鉴。Objective To analyze the total effective rate of fenmatong tablets in patients with menstrual disorders.Methods 116 patients with menstrual disorders in our hospital from May 2018 to may 2020 were enrolled in the study.They were randomly divided into two groups(n=58 in each group).The control group was treated with kelingmeng tablets and the experimental group was treated with fenmatong tablets.The clinical efficacy,ovarian hormone level,incidence of adverse reactions and SF-36 score between the two groups were compared.Results The clinical total effective rate of the experimental group(96.55%)was higher than that of the control group(74.14%),the serum Eand P of the experimental group after treatment were higher than those of the control group,the differences were statistically significant(P<0.05).The incidence of adverse reactions in the experimental group(3.45%)was lower than that in the control group(15.52%).The SF-36 score in the expeirmental group was higher than that in the control group after treatment,and the differences were statistically significant(P<0.05).Conclusion Fenmatong tablets can effectively regulate the menstrual cycle and ovarian hormone levels of patients with menstrual disorders,improve the lifequality,and has less adverse reactions,which is worthy of reference.

关 键 词:芬吗通片 月经失调 卵巢激素 临床疗效 

分 类 号:R711.51[医药卫生—妇产科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象